Peptide receptor radionuclide therapy with 177Lu-DOTATATE for metastatic neuroendocrine tumor occurring in association with multiple endocrine neoplasia type 1 and cushing's syndro...

Por Chinna Naik, Sandip Basu
Publicado em 2017-04-01

177Lu-DOTATATE peptide receptor radionuclide therapy in patients with borderline low and discordant renal parameters: Treatment feasibility assessment by sequential estimation of t...

Por Chinna Naik, Sandip Basu
Publicado em 2018-01-01

Clinical efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in thyroglobulin-elevated negative iodine scintigraphy: A “not-so-promising” result compared to GEP-NETs...

Por Sandip Basu, Rahul Parghane, Chinna Naik
Publicado em 2020-07-01